Products
Online Inquiry
Ki8751
Cat. No.:
OB0225WX-2413
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Ki8751 is a potent VEGFR2 inhibitor (IC50: 0.9 nM) that exhibits over 40-fold selectivity compared to c-Kit, PDGFR-alpha, and FGFR-2.
Synonym:
228559-41-9; Ki 8751; Ki-8751; N-(2,4-Difluorophenyl)-N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]urea; 1-(2,4-difluorophenyl)-3-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-2-fluorophenyl)urea; 1-(2,4-difluorophenyl)-3-[4-(6,7-dimethoxyquinolin-4-yl)oxy-2-fluorophenyl]urea; 1-(2,4-Difluorophenyl)-3-(4-(6,7-dimethoxyquinolin-4-yl)oxy-2-fluorophenyl)urea; 1-(2,4-difluorophenyl)-3-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]-2-fluorophenyl}urea; N-(2,4-Difluorophenyl)-N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy)-2-fluorophenyl)urea; Urea, N-(2,4-difluorophenyl)-N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy)-2-fluorophenyl)-; MFCD09971092; 1-(2,4-difluorophenyl)-3-(4-(6,7-dimethoxyquinolin-4-yloxy)-2-fluorophenyl)urea; 1-(2,4-Difluoro-phenyl)-3-[4-(6,7-dimethoxy-quinolin-4-yloxy)-2-fluoro-phenyl]-urea; 1-(2,4-difluorophenyl)-3-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]-2-fluorophenyl]urea; N-(2,4-difluorophenyl)-N'-(4-((6,7-dimethoxy-4-quinolyl)oxy)-2-fluorophenyl)urea
CAS No.:
228559-41-9
Compound CID:
11317348
Formula:
C24H18F3N3O4
Formula Weight:
469.41
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Ki8751 is employed in oncology research as a potent and selective VEGFR2 tyrosine kinase inhibitor to investigate the suppression of tumor-induced angiogenesis and the disruption of vascular signaling.
Library Information
Target:
c-Kit; PDGFR; VEGFR
Receptor:
c-Kit; PDGFR; VEGFR
Pathways:
Protein tyrosine kinase
Plate Number:
L6700-01
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
47 mg/mL; 100.13 mM
ALogP:
4.853
HBA_Count:
5
HBD_Count:
2
Rotatable Bond:
6





